Zhengye Biotechnology Holding (ZYBT) Cash & Current Investments (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Cash & Current Investments data on file, last reported at $7.3 million in Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $7.3 million, up 161.86% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.3 million (up 161.86% YoY), and the FY2025 annual result was $7.2 million, up 161.22% from the prior year.
• Cash & Current Investments advanced to $7.3 million in Q4 2025 per ZYBT's latest filing, from $2.9 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $7.3 million in Q4 2025 and troughed at $2.8 million in Q4 2024.
• A 3-year average of $4.2 million and a median of $3.4 million in 2023 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments decreased 29.3% in 2024, then surged 161.86% in 2025.
• A 3-year view of Cash & Current Investments shows it stood at $3.9 million in 2023, then slipped by 29.3% to $2.8 million in 2024, then surged by 161.86% to $7.3 million in 2025.
• Business Quant data shows ZYBT's Cash & Current Investments at $7.3 million in Q4 2025, $2.9 million in Q2 2025, and $2.8 million in Q4 2024.